Alignment Healthcare (NASDAQ:ALHC) President Dawn Christine Maroney Sells 122,707 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Maroney sold 122,707 shares of the company’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $12.68, for a total value of $1,555,924.76. Following the completion of the transaction, the president owned 794,606 shares of the company’s stock, valued at approximately $10,075,604.08. This represents a 13.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, June 15th, Dawn Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $19.55, for a total transaction of $586,500.00.

Alignment Healthcare Trading Down 1.2%

NASDAQ ALHC opened at $12.61 on Friday. The stock has a market cap of $2.62 billion, a P/E ratio of 66.37 and a beta of 1.11. The company’s fifty day simple moving average is $16.17 and its 200-day simple moving average is $18.03. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 1.22. Alignment Healthcare, Inc. has a 52 week low of $12.39 and a 52 week high of $25.12.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.04. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The business had revenue of $1.34 billion during the quarter, compared to analyst estimates of $1.31 billion. During the same period last year, the business earned $0.07 EPS. The business’s revenue was up 31.6% on a year-over-year basis. Equities research analysts predict that Alignment Healthcare, Inc. will post 0.17 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. WINTON GROUP Ltd acquired a new stake in shares of Alignment Healthcare in the 2nd quarter valued at about $1,164,000. Arizona State Retirement System grew its stake in Alignment Healthcare by 15.8% in the second quarter. Arizona State Retirement System now owns 53,553 shares of the company’s stock worth $1,275,000 after purchasing an additional 7,318 shares in the last quarter. Nykredit A S bought a new stake in Alignment Healthcare in the second quarter valued at about $36,000. Corient Private Wealth LP increased its holdings in Alignment Healthcare by 128.2% in the second quarter. Corient Private Wealth LP now owns 136,505 shares of the company’s stock valued at $3,250,000 after buying an additional 76,677 shares during the last quarter. Finally, HighTower Advisors LLC acquired a new stake in Alignment Healthcare during the second quarter valued at approximately $755,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. UBS Group reiterated a “neutral” rating on shares of Alignment Healthcare in a research note on Wednesday, July 8th. TD Cowen restated a “buy” rating on shares of Alignment Healthcare in a research note on Monday, August 3rd. Wall Street Zen downgraded Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. JPMorgan Chase & Co. cut their target price on Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 4th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Alignment Healthcare in a research report on Tuesday, August 4th. Seven investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $23.60.

Key Alignment Healthcare News

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: CEO John Kao’s sales were conducted under a pre-arranged Rule 10b5-1 plan and were intended to cover tax-withholding obligations tied to vested equity awards, reducing the likelihood that the transactions reflect a negative view of Alignment Healthcare’s business prospects. SEC Form 4 filing
• Neutral Sentiment: Alignment Health’s annual survey reported worsening challenges for seniors related to aging in place, support gaps and medical debt. The announcement highlights issues relevant to the company’s target market but does not provide a direct change to revenue, enrollment or earnings expectations. Alignment Health senior survey
• Neutral Sentiment: Reported short interest was zero shares, with a zero-day short-interest ratio. Because the figures show no measurable short position, they provide little evidence of either bearish positioning or potential short-covering support.
• Negative Sentiment: CEO John Kao sold a combined 557,870 shares across September 10–11, worth approximately $7.1 million, reducing his reported ownership. President Dawn Maroney also sold 122,707 shares for about $1.6 million. Although the transactions were tied to tax obligations, their size and timing can weigh on sentiment and may be contributing to the stock’s decline. SEC Form 4 filing
• Negative Sentiment: Kaplan Fox announced an investigation into Alignment Healthcare for possible securities-law violations. The announcement does not establish wrongdoing, but it introduces legal and reputational uncertainty that can pressure the stock. Kaplan Fox investigation announcement

Alignment Healthcare Company Profile

Alignment Healthcare, Inc is a technology-enabled healthcare company that provides Medicare Advantage health plans and care-management services for older adults. Through its Alignment Health Plan subsidiary, the company offers insurance coverage designed for Medicare-eligible members, including primary and specialty care coordination, prescription drug benefits, preventive services and access to a network of healthcare providers.

The company combines health-plan operations with proprietary technology intended to support personalized care.